Table 2.
Characteristics of the 108 samples used for the diversity analysis of the healthy vaginal microbiota.
| Sample | n = 108 | |
|---|---|---|
| Age | ||
| ≤25 years | 46 | 42.59% |
| 26–35 years | 40 | 37.04% |
| >35 years | 22 | 20.37% |
| History of salpingitis | 2 | 1.85% |
| History of mTSS | 1 | 0.93% |
| Tampon brand | ||
| Tampax ® | 43 | 39.81% |
| Nett® | 29 | 26.85% |
| Carrefour® | 8 | 7.41% |
| OB® | 5 | 4.63% |
| Leader Price® | 5 | 4.63% |
| Others | 18 | 16.67% |
| Tampon use duration | ||
| median 4 h 30 [range 27 min-24 h] | ||
| 0–4 h | 49 | 45.37% |
| 4–8 h | 51 | 47.22% |
| >8 h | 7 | 6.48% |
| NA | 1 | 0.93% |
| Antibiotic use in the previous 15 days | ||
| Total | 2 | 1.85% |
| Doxycycline | 1 | 0.93% |
| Tetralysal | 1 | 0.93% |
| Contraceptive method | ||
| None | 33 | 30.56% |
| Oestroprogestative pill | 60 | 55.56% |
| Intra-uterine device | 14 | 12.96% |
| NA | 1 | 0.93% |
| Sexual intercourse in the previous 5 days | ||
| Yes | 40 | 37.04% |
| No | 66 | 61.11% |
| NA | 2 | 1.85% |
mTSS, menstrual toxic shock syndrome; NA, not available.
Collected information came from the survey accompanying each sample.